LLY Sep 2024 320.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:22PM EDT. Market open.
| Previous close | 344.72 |
| Open | N/A |
| Bid | 467.95 |
| Ask | 473.85 |
| Strike | 320.00 |
| Expiry date | 2024-09-20 |
| Day's range | 344.72 - 344.72 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
Yahoo Finance3 stocks with the biggest gains took April's biggest losses
The stock market's very rough April saw some of the biggest gainers of the first three months take some of the biggest dings to their market caps. And at the same time, some of the sectors that struggled in Q1 saw a similar reversal of fortune in April.
Yahoo FinanceEli Lilly reports $2 billion from Mounjaro, Zepbound in Q1 2024
Eli Lilly missed on total sales in the first quarter, but its GLP-1 drugs helped boost sales by 26% over those in Q1 2023.
ZacksETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook
Eli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro.
© 2024 Yahoo. All rights reserved.